###begin article-title 0
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Leishmania-Induced IRAK-1 Inactivation Is Mediated by SHP-1 Interacting with an Evolutionarily Conserved KTIM Motif
###end article-title 0
###begin p 1
Conceived and designed the experiments: IAD MO. Performed the experiments: IAD MTS. Analyzed the data: IAD MTS BC MO. Contributed reagents/materials/analysis tools: SS SA. Wrote the paper: IAD BC MO.
###end p 1
###begin p 2
###xml 17 27 17 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 273 283 273 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 507 517 507 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1036 1037 1036 1037 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</underline>
###xml 1043 1044 1043 1044 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 1057 1058 1057 1058 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 1068 1069 1068 1069 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</underline>
Parasites of the Leishmania genus can rapidly alter several macrophage (MO) signalling pathways in order to tame down the innate immune response and inflammation, therefore favouring their survival and propagation within their mammalian host. Having recently reported that Leishmania and bacterial LPS generate a significantly stronger inflammatory response in animals and phagocytes functionally deficient for the Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1), we hypothesized that Leishmania could exploit SHP-1 to inactivate key kinases involved in Toll-like receptor (TLR) signalling and innate immunity such as IL-1 receptor-associated kinase 1 (IRAK-1). Here we show that upon infection, SHP-1 rapidly binds to IRAK-1, completely inactivating its intrinsic kinase activity and any further LPS-mediated activation as well as MO functions. We also demonstrate that the SHP-1/IRAK-1 interaction occurs via an evolutionarily conserved ITIM-like motif found in the kinase domain of IRAK-1, which we named KTIM (Kinase Tyrosyl-based Inhibitory Motif). This regulatory motif appeared in early vertebrates and is not found in any other IRAK family member. Our study additionally reveals that several other kinases (e.g. Erk1/2, IKKalpha/beta) involved in downstream TLR signalling also bear KTIMs in their kinase domains and interact with SHP-1. We thus provide the first demonstration that a pathogen can exploit a host protein tyrosine phosphatase, namely SHP-1, to directly inactivate IRAK-1 through a generally conserved KTIM motif.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 752 762 752 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1189 1199 1189 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Leishmania developed several methods to seize control of macrophage signalling pathways in an effort to inactivate their killing abilities. One effective method utilized by the parasite is the activation of host protein tyrosine phosphatases, specifically SHP-1. This increased phosphatase activity contributes to the inactivation of signalling molecules involved in critical macrophage functions such as NO and cytokine production. Interestingly, the absence of SHP-1 results in stronger macrophage inflammatory responses to a bacterial cell wall component known as LPS, a molecule detected by macrophages through Toll-like receptors (TLRs). This observation suggested a role for SHP-1 in the regulation of TLR signalling. Our study reveals that upon Leishmania infection, SHP-1 is able to rapidly bind to and inactivate a critical kinase (IRAK-1) in this pathway. This regulatory binding was shown to be mediated by an evolutionarily conserved motif identified in the kinase. This motif was also present in other kinases involved in Toll signalling and therefore could represent a regulatory mechanism of relevance to many kinases. This work not only reports a unique mechanism by which Leishmania can avoid harmful TLR signalling, but also provides a platform on which extensive investigation on host evasion mechanisms and regulation of cellular kinases can be gained.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Takeda1">[1]</xref>
###xml 118 128 118 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier1">[2]</xref>
###xml 448 451 448 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget1">[3]</xref>
###xml 661 671 654 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 682 685 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget1">[3]</xref>
Innate inflammatory responses play a critical role in controlling pathogens [1]. However, protozoan parasites such as Leishmania evolved strategies to avoid phagocyte activation by seizing control of key signalling pathways, therefore favouring their invasion and survival within the host cell [2]. We recently reported that the protein tyrosine phosphatase (PTP) SHP-1 plays a pivotal role in taming down phagocyte-mediated inflammatory responses [3]. For instance, we showed that in the absence of SHP-1, several pro-inflammatory cytokines (e.g. IL-1beta, IL-6, TNFalpha) and chemokines, as well as inflammatory neutrophil recruitment were all exacerbated by Leishmania infection [3]. Of interest, we also found that LPS mediates an excessive inflammatory response in the absence of SHP-1, therefore suggesting that SHP-1 could exert its negative regulatory action via Toll like receptor (TLR) signalling.
###end p 6
###begin p 7
###xml 136 139 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier1">[2]</xref>
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget1">[3]</xref>
###xml 194 204 194 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 549 559 545 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 570 573 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier1">[2]</xref>
###xml 574 577 570 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Cameron1">[4]</xref>
###xml 578 581 574 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Carrera1">[5]</xref>
As SHP-1 can interact with various members of the JAK and MAP kinase families in physiological, immune response, and infection contexts [2],[3], we explored the possibility that the capacity of Leishmania to block the macrophage (MO) inflammatory response could result from rapid IRAK-1 kinase inactivation through SHP-1 action. This hypothesis is further reinforced by the fact that several LPS-mediated MO functions (e.g. TNFalpha, NO, IL-12), critical for the containment of pathogens and adaptive immune response development, are inhibited upon Leishmania infection [2],[4],[5].
###end p 7
###begin p 8
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Lang1">[6]</xref>
###xml 441 451 441 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 530 533 530 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget1">[3]</xref>
###xml 685 688 681 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget2">[7]</xref>
###xml 689 692 685 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Massa1">[9]</xref>
###xml 861 866 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPN6</italic>
###xml 943 947 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Alonso1">[10]</xref>
###xml 892 898 <span type="species:ncbi:9606">humans</span>
Whereas invertebrates depend mainly on the evolutionarily conserved innate immune system to fight off pathogens, vertebrates have developed a sophisticated adaptive immune system, hence the need to regulate the innate immune response. The TLR family has been shown to play a key role in triggering innate immunity as well as the subsequent induction of adaptive immune responses in vertebrates [6]. Our previous findings reporting augmented Leishmania- and LPS-induced innate inflammatory response in the absence of SHP-1 (PTPN6) [3], and the several reports that key transcription factors (NF-kappaB and AP-1) related to TLR signalling were strongly activated in the absence of SHP-1 [7]-[9], suggested the importance of SHP-1 in the negative regulation of TLR signalling and its subsequent inflammatory response in vertebrates. Of interest, a mutation in the PTPN6 gene coding for SHP-1 in humans has been recently linked to Sezary syndrome [10], a T-cell cutaneous lymphoma arising from chronic inflammatory state.
###end p 8
###begin p 9
###xml 290 300 290 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-An1">[11]</xref>
From these observations, and given the fact that IRAK-1 serves as a crucial kinase in all MyD88-dependent pathways leading to the activation of innate inflammatory responses, we hypothesised that SHP-1 is a critical player in the negative regulation of this kinase that can be exploited by Leishmania. For instance, until recently there was no indication that SHP-1 could interact with IRAK-1. However, a recent study by Cao's laboratory [11] provided strong evidence that SHP-1 can interact with IRAK-1.
###end p 9
###begin p 10
###xml 121 131 121 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 607 616 607 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
Here, we provide evidence that SHP-1 negatively regulates IRAK-1 intrinsic kinase activity in its resting state and upon Leishmania infection through binding to an evolutionarily conserved ITIM-like motif located within IRAK-1's kinase domain. In addition, it is important to stress that this is the first mention of this motif to be found within a kinase, as to date it has only been found within the intracytoplasmic portion of immunoglobin (Ig)-like receptors. Of interest, we also discovered that this ITIM-like motif was present in several other kinases. Finally, our study also provides evidence from in silico sequence analyses that both IRAK-1 and SHP-1 evolutionarily emerged in vertebrates concomitantly with the development of a better-controlled innate immune response. Therefore the appearance of this key interaction in early vertebrates may have also contributed to the development of the more complex adaptive immune response.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Cell culture and reagents
###end title 12
###begin p 13
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 120 125 120 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">me/me</sup>
###xml 115 125 115 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6<sup>me/me</sup></italic>
###xml 136 138 136 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">me</italic>
###xml 139 141 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">me</italic>
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">me</italic>
###xml 215 218 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget2">[7]</xref>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sup>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Radzioch1">[12]</xref>
###xml 437 443 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 437 443 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
The immortalized me-3 (SHP-1-/-) and LM-1 (WT) bone marrow-derived MOs (BMDMs) were generated from motheaten mice (Ptpn6me/me; C3HeBFeJ me/me) and their respective wild-type littermates (C3HeBFeJ me/+) as described [7]. The immortalized B10R BMDMs were derived from B10A.Bcgr mice [12]. L929 cells used for the TNF bioassays were grown in RPMI-1640 medium (5% FBS). MO-activating lipopeptide-2 (MALP-2) and lipopolysaccharide (LPS) from E.coli were purchased from Alexis Biochemicals, San Diego, CA. Flagellin and CpG DNA were purchased from Invivogen, San Diego, CA. IRAK1/4 inhibitor (N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole) was purchased from Calbiochem, La Jolla, CA.
###end p 13
###begin title 14
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro infection
###end title 14
###begin p 15
###xml 0 33 0 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani infantum, L. mexicana</italic>
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 105 118 105 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. tarentolae</italic>
###xml 0 20 <span type="species:ncbi:5671">L. donovani infantum</span>
###xml 22 33 <span type="species:ncbi:5665">L. mexicana</span>
###xml 53 61 <span type="species:ncbi:5664|species:ncbi:419269|species:ncbi:55468|species:ncbi:488399|species:ncbi:225018">L. major</span>
###xml 105 118 <span type="species:ncbi:5689">L. tarentolae</span>
L. donovani infantum, L. mexicana (MNYC/BZ/62/M379), L. major Friedlin strain (MHOM/JL/80/Friedlin), and L. tarentolae strain TAR II promastigotes were kept in SDM medium (10% FBS), and stationary phase parasites were used to infect cells in a parasite to MO ratio of 20:1. Non-internalized parasites were removed by washing the plates with phosphate-buffered saline (PBS), after which MOs were collected for subsequent experiments.
###end p 15
###begin title 16
Western blot analysis
###end title 16
###begin p 17
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier2">[13]</xref>
###xml 317 323 <span type="species:ncbi:9986">rabbit</span>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
###xml 338 349 <span type="species:ncbi:3704">horseradish</span>
Western blotting was performed as previously described [13]. Proteins were detected using antibodies directed against IRAK-1 (generated in the laboratory of Dr. Akira), SHP-1 and phospho-tyrosine (clone 4G10) (Upstate, Charlottesville, VA), and actin (Sigma-Aldrich, ON, Canada). Proteins were detected using an anti-rabbit or anti-mouse horseradish peroxidase (HRP)-conjugated antibody (Amersham, QC, Canada) and visualized using ECL western blotting detection system (Amersham).
###end p 17
###begin title 18
IRAK-1/IRAK-4 kinase assay
###end title 18
###begin p 19
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 627 628 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 638 639 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 737 739 705 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
6x106 MOs were lysed in cold lysis buffer (20mM Tris (pH 7.5), 1mM EDTA, 150mM NaCl, 1% Igepal, 10mM beta-glycerophosphate, 1mM sodium orthovanadate, 25 microg/ml aprotinin and 25 microg/ml leupeptin). Lysates were precleared with protein A/G agarose beads (Santa Cruz, CA). Samples were then centrifuged (13,000x g, 10 min) and supernatants kept. IRAK-1 or IRAK-4 antibody and protein A/G agarose beads were added to the supernatant and samples were incubated O/N at 4degreesC. Beads were spun down and washed with the lysis buffer described above, followed by washes with the kinase assay buffer (20mM HEPES pH 7.5, 20mM MgCl2, 3mM MnCl2, and 10mM beta-glycerophosphate). Kinase assay buffer (20 microl) containing 10 microCi of gamma-32P (Amersham) was then added to the beads and samples incubated (30 min, 30degreesC). The reaction was stopped by the addition of 4x sample loading buffer (12.5% Tris-HCl (pH 6.8), 10% glycerol, 10% SDS, 5% beta-mercaptoethanol, 0.05% bromophenol blue). Samples were boiled and ran on SDS-PAGE. Bands were detected using X-ray Kodak films (Amersham) or by image analyzer (BioRad, Canada).
###end p 19
###begin title 20
In gel PTP assay
###end title 20
###begin p 21
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 427 429 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 554 558 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Markova1">[14]</xref>
For immunoprecipitation samples, 6x106 MOs were lysed as described previously for the IRAK-1 kinase assay without the addition of sodium orthovanadate to the lysis buffer. Cell lysate controls (25 microg) were obtained using a PTP lysis buffer (50mM Tris (pH 7.0), 0.1mM EDTA, 0.1mM EGTA, 0.1% beta-mercaptoethanol, 1% Igepal, 25 microg/ml aprotinin and 25 microg/ml leupeptin). Samples were loaded on a gel containing a gamma-32P-labelled poly(Glu4Tyr) peptide (Sigma-Aldrich) and the SHP-1 band was observed by in gel PTP assay as previously described [14].
###end p 21
###begin title 22
Co-immunoprecipitation
###end title 22
###begin p 23
###xml 239 242 <span type="species:ncbi:10116">rat</span>
Samples were lysed in the western blot lysis buffer (no sodium orthovanadate was added when immunoprecipitating SHP-1) and immunoprecipitated using protein A/G agarose beads (Santa Cruz) and 4 microg of the IRAK-1, SHP-1 antibody, or anti-rat antibody (Sigma-Aldrich) for non-specific binding. Beads were spun down and washed three times with lysis buffer. Beads were resuspended in the 4x western sample loading buffer previously described and boiled supernatants were loaded on SDS-PAGE and western blot analysis was performed as described above.
###end p 23
###begin title 24
GST pull-down assay
###end title 24
###begin p 25
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 242 244 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 691 699 679 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
Wildtype mouse IRAK-1 gene and the IRAK-1 genes of the different KTIM mutants (all in PCDNA3 vectors) were in vitro translated using the Promega TNT Quick Coupled Transcription/Translation kit (Fisher Scientific, ON, Canada) using 20 microCi 35S (Amersham). The active or the trapping mutant of GST SHP-1 was produced in BL21 bacteria. Bacterial lysates were extracted using the BugBuster Protein Extraction Reagent (VWR CANLAB, ON, Canada), and the GST protein (5 microg) was pulled down from bacterial lysates using glutathione sepharose beads (30 microl) (Amersham). The active/trapping mutant of GST-SHP-1 bound to glutathione beads was left to interact with immunoprecipitates (IPs) or in vitro translated IRAK-1 protein in a PTP reaction buffer (50mM Hepes (pH 7.5), 0.1% beta-mercaptoethanol) for 1 h at RT. When in vitro translation of IRAK-1 was performed, GST-SHP-1 was allowed to interact with IRAK-1 in a 5:1 ratio. Beads were then spun down, washed 3x with the PTP lysis buffer, then resuspended in 4x sample loading buffer (20 microl), boiled, and loaded on SDS-PAGE. IRAK-1 bands were revealed by exposing to X-ray film (Amersham).
###end p 25
###begin title 26
Alkali-resistance phosphoprotein assay
###end title 26
###begin p 27
###xml 375 377 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Bourassa1">[15]</xref>
Kinase assays were run on SDS-PAGE as described above, pre-treatment image is taken by exposing the gel to a phospho-imager screen. Next, gels were fixed overnight at RT in a 10% methanol/7% acetic acid solution. Gels were then soaked in a 10% glutaraldehyde solution (30 min, RT) with gentle shaking and rinsed in water prior to incubation with KOH. The alkali treatment of 32P-labelled IRAK-1 was performed as previously described [15].
###end p 27
###begin title 28
Generation of IRAK-1 mutants
###end title 28
###begin p 29
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse IRAK-1 gene cloned into a PCDNA3 plasmid was mutated at different sites within the KTIM using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) as instructed by the manufacturer. The primers (all synthesized by Genome Quebec, Montreal, QC, Canada) designed to create the mutants were:
###end p 29
###begin p 30
For the tyrosine to phenylalanine mutation;
###end p 30
###begin p 31
###xml 7 49 7 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGCTTATACTGCCTTGTTTTTGGCTTCTTGCCCAATGG3&#8242;</named-content>
sense: 5'GGCTTATACTGCCTTGTTTTTGGCTTCTTGCCCAATGG3';
###end p 31
###begin p 32
###xml 12 54 12 54 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATTGGGCAAGAAGCCAAAAACAAGGCAGTATAAGCC3&#8242;</named-content>
anti-sense: 5'CCATTGGGCAAGAAGCCAAAAACAAGGCAGTATAAGCC3'.
###end p 32
###begin p 33
For the leucine to methionine mutation;
###end p 33
###begin p 34
###xml 7 49 7 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGCTTATACTGCCTTGTTTATGGCTTCATGCCCAATGG3&#8242;</named-content>
sense: 5'GGCTTATACTGCCTTGTTTATGGCTTCATGCCCAATGG3';
###end p 34
###begin p 35
###xml 12 54 12 54 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATTGGGCATGAAGCCATAAACAAGGCAGTATAAGCC3&#8242;</named-content>
anti-sense: 5'CCATTGGGCATGAAGCCATAAACAAGGCAGTATAAGCC3'.
###end p 35
###begin p 36
For the glycine to alanine, phenylalanine to tyrosine, leucine to methionine triple mutation, sequential mutagenesis was performed where the above-mentioned leucine mutation was used as the template to generate an additional glycine to alanine mutation using the primers:
###end p 36
###begin p 37
###xml 7 49 7 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGCTTATACTGCCTTGTTTATGCCTTCATGCCCAATGG3&#8242;</named-content>
sense: 5'GGCTTATACTGCCTTGTTTATGCCTTCATGCCCAATGG3';
###end p 37
###begin p 38
###xml 12 54 12 54 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATTGGGCATGAAGGCATAAACAAGGCAGTATAAGCC3&#8242;</named-content>
anti-sense: 5'CCATTGGGCATGAAGGCATAAACAAGGCAGTATAAGCC3'.
###end p 38
###begin p 39
Finally, a phenylalanine to tyrosine mutation was generated using the previously described double mutation as a template using the primers:
###end p 39
###begin p 40
###xml 7 49 7 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGCTTATACTGCCTTGTTTATGCCTACATGCCCAATGG3&#8242;</named-content>
sense: 5'GGCTTATACTGCCTTGTTTATGCCTACATGCCCAATGG3';
###end p 40
###begin p 41
###xml 12 54 12 54 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATTGGGCATGTAGGCATAAACAAGGCAGTATAAGCC3&#8242;</named-content>
anti-sense: 5'CCATTGGGCATGTAGGCATAAACAAGGCAGTATAAGCC3'.
###end p 41
###begin p 42
###xml 165 187 165 187 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TTCCTCCACCAAGTCAAG3&#8242;</named-content>
###xml 192 216 192 216 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCTGAGGAGTACATCAAGAC3&#8242;</named-content>
All mutations were verified by sequencing the entire plasmid using the T7 and SP6 primers (provided by Genome Quebec, Montreal, QC, Canada) and the internal primers 5'TTCCTCCACCAAGTCAAG3' and 5'CCTGAGGAGTACATCAAGAC3'.
###end p 42
###begin title 43
IL-12 mRNA expression analysis
###end title 43
###begin p 44
###xml 596 633 552 589 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGG ATT TGG CCG TAT TGG GCG CCT-3&#8242;</named-content>
###xml 638 676 594 632 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">3&#8242;- ACA TAC TCA GCA CCG GCC TCA CCC-5&#8242;</named-content>
###xml 685 718 641 674 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGA AGC ACG GCA GCA GAA TA-3&#8242;</named-content>
###xml 723 760 679 716 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">3&#8242;-AAC TTG AGG GAG AAG TAG GAA TGG-5&#8242;</named-content>
RNA was extracted from MOs using TRIzol reagent (Invitrogen Canada, ON, Canada). Reverse transcription was performed using oligodT. Quantitative Real-Time PCR (qRT-PCR) was performed with a Corbett Research Rotorgene (Corbett Life Science, Sydney, Australia), using Invitrogen Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen) and 0.4 microM primer in 25 microl. qPCR program is: 50degreesC 2 min; 95degreesC 3 min; (95degreesC 20 sec, 60degreesC 30 sec, 72degreesC 20 sec) for 40 cycles followed by a melting curve. All primers annealing temperature was 60degreesC. Oligo sequences are: GAPDH: 5'-CGG ATT TGG CCG TAT TGG GCG CCT-3' and 3'- ACA TAC TCA GCA CCG GCC TCA CCC-5'; IL-12: 5'- GGA AGC ACG GCA GCA GAA TA-3' and 3'-AAC TTG AGG GAG AAG TAG GAA TGG-5'.
###end p 44
###begin title 45
TNF bioassay
###end title 45
###begin p 46
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-RibeiroDias1">[16]</xref>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
TNF bioassay was performed as previously described [16]. Briefly, TNF-sensitive L929 fibroblasts were seeded in 96-well plates in a concentration of 3.5x104 cells/100 microl/well in RPMI-1640 (5% FBS) medium and incubated for 24 h until obtaining a monolayer. Supernatants from designated experiments were added to L929 cells and serially diluted in the presence of actinomycin D (2 microg/ml). After incubation (18-24 h, 37degreesC), the L929 monolayers were stained with crystal violet, washed with distilled water, and left to dry. Then, methanol was added to dissolve the stain and cytotoxicity was determined by measuring absorbance at 595 nm. One unit of TNF was referred to as the reciprocal of the dilution that induced 50% of L929 cell lysis.
###end p 46
###begin title 47
NO assay
###end title 47
###begin p 48
###xml 139 142 139 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget1">[3]</xref>
NO production was evaluated by measuring the accumulation of nitrite in the culture medium by the Griess reaction, as previously described [3].
###end p 48
###begin title 49
Electrophoretic mobility shift (EMSA)
###end title 49
###begin p 50
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Jaramillo1">[17]</xref>
###xml 199 201 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 349 377 341 369 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTTGAGGGGACTTTCCCAGGC-3&#8242;</named-content>
###xml 444 472 436 464 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTCGATCGGGGCGGGGCGAGC-3&#8242;</named-content>
Nuclear extracts were prepared by a standard protocol, and EMSAs were performed as previously described [17]. Briefly, nuclear extracts were incubated with binding buffer containing 1.0 ng of [gamma-32P] dATP radiolabeled double-stranded DNA oligonucleotide for 20 min at room temperature. The DNA binding consensus sequence used for NF-kappaB was (5'-AGTTGAGGGGACTTTCCCAGGC-3'). Sp1 consensus oligonucleotide was used as non-specific control (5'-ATTCGATCGGGGCGGGGCGAGC-3') (Santa Cruz). DNA-protein complexes were resolved by electrophoresis in native 4% (w/v) polyacrylamide gels. The gels were then dried and autoradiographed.
###end p 50
###begin title 51
pNPP phosphatase assay
###end title 51
###begin p 52
MOs were collected, lysed in the PTP lysis buffer described previously and kept on ice for 45 min. Lysates were cleared by centrifugation, and protein content was determined by Bradford reagent followed by IP. Equal amounts of IPs were incubated in a phosphatase reaction mix (50mM Hepes (pH 7.5), 0.1% beta-mercaptoethanol, 10mM pNPP) overnight at 37degreesC. OD was then read at 405 nm.
###end p 52
###begin title 53
Sequence alignments
###end title 53
###begin p 54
###xml 285 297 285 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 328 343 328 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 370 386 370 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis familiaris</italic>
###xml 414 424 414 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bos Taurus</italic>
###xml 450 462 450 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 486 503 486 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 543 561 543 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 597 608 597 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 702 716 702 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 843 856 843 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gallus gallus</italic>
###xml 917 934 917 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Euprymna scolopes</italic>
###xml 967 996 967 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Strongylocentrotus purpuratus</italic>
###xml 1018 1040 1018 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 1071 1085 1071 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apis mellifera</italic>
###xml 1119 1142 1119 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 285 297 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 316 326 <span type="species:ncbi:9598">chimpanzee</span>
###xml 328 343 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 365 368 <span type="species:ncbi:9615">dog</span>
###xml 370 386 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 450 462 <span type="species:ncbi:10090">Mus musculus</span>
###xml 481 484 <span type="species:ncbi:10116">rat</span>
###xml 486 503 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 543 561 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 586 595 <span type="species:ncbi:7955">zebrafish</span>
###xml 597 608 <span type="species:ncbi:7955">Danio rerio</span>
###xml 630 635 <span type="species:ncbi:9606">human</span>
###xml 653 663 <span type="species:ncbi:9598">chimpanzee</span>
###xml 687 700 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 702 716 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 741 744 <span type="species:ncbi:9615">dog</span>
###xml 787 792 <span type="species:ncbi:10090">mouse</span>
###xml 810 813 <span type="species:ncbi:10116">rat</span>
###xml 834 841 <span type="species:ncbi:9031">chicken</span>
###xml 843 856 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 881 890 <span type="species:ncbi:7955">zebrafish</span>
###xml 917 934 <span type="species:ncbi:6613">Euprymna scolopes</span>
###xml 967 996 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
###xml 1018 1040 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 1061 1069 <span type="species:ncbi:7460">honeybee</span>
###xml 1071 1085 <span type="species:ncbi:7460">Apis mellifera</span>
###xml 1119 1142 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 1162 1169 <span type="species:ncbi:9031">chicken</span>
###xml 1193 1198 <span type="species:ncbi:10090">mouse</span>
###xml 1214 1219 <span type="species:ncbi:10090">mouse</span>
###xml 1235 1240 <span type="species:ncbi:10090">mouse</span>
###xml 1256 1261 <span type="species:ncbi:10090">mouse</span>
###xml 1277 1282 <span type="species:ncbi:10090">mouse</span>
###xml 1298 1303 <span type="species:ncbi:10090">mouse</span>
###xml 1320 1325 <span type="species:ncbi:10090">mouse</span>
###xml 1340 1345 <span type="species:ncbi:10090">mouse</span>
###xml 1366 1371 <span type="species:ncbi:10090">mouse</span>
###xml 1391 1396 <span type="species:ncbi:10090">mouse</span>
Sequences were obtained from the NCBI protein database. Sequence alignments used to calculate identity and similarity percentages were generated by EMBOSS local pair-wise alignment algorithms program (). The accession numbers of the protein sequences included in the study are: human (Homo sapiens) IRAK-1 (P51617), chimpanzee (Pan troglodytes) IRAK-1 (XP_521332), dog (Canis familiaris) IRAK-1 (XP_549367), bull (Bos Taurus) IRAK-1 (Q2LGB3), mouse (Mus musculus) IRAK-1 (Q62406), rat (Rattus norvegicus) IRAK-1 (XP_001057078), tropical frog (Xenopus tropicalis) IRAK-1 (NP_001006713), zebrafish (Danio rerio) IRAK-1 (XP_697688), human IRAK-4 (Q9NWZ3), chimpanzee IRAK-4 (XP_001166114), rhesus monkey (Macaca mulatta) IRAK-4 (XP_001091707), dog IRAK-4 (XP_543727), bull IRAK-4 (Q1RMT8), mouse IRAK-4 (Q8R4K2), rat IRAK-4 (XP_217026), chicken (Gallus gallus) IRAK-4 (NP_001025909), zebrafish IRAK-4 (AAT37635), squid (Euprymna scolopes) IRAK-4 (AAY27972), sea urchin (Strongylocentrotus purpuratus) IRAK-4 (XP_784716), Caenorhabditis elegans IRAK-4 (NP_502587), honeybee (Apis mellifera) pelle-like protein (XP_624002), Drosophila melanogaster pelle (NP_476971), chicken IRAK-2 (NP_001025776), mouse JAK2 (Q62120), mouse JAK3 (Q62137), mouse TAK1 (Q62073), mouse Erk1 (Q63844), mouse Erk2 (P63085), mouse JNK (CAC88132), mouse p38 (P47811), mouse IKK-alpha (Q60680), mouse IKK-beta (O88351), mouse LYN (AAH31547).
###end p 54
###begin title 55
Band quantification
###end title 55
###begin p 56
All densitometric analyses were performed using the Quantity One software, Biorad Laboratories Inc. Values and standard deviations observed represent scans of three independent experiments.
###end p 56
###begin title 57
Ethical oversight
###end title 57
###begin p 58
###xml 117 121 <span type="species:ncbi:10090">mice</span>
The bone marrow-derived macrophages described in this study have been previously derived from WT and SHP-1 deficient mice (see reference 7), and immortalized as cell lines. However, experiments done on the animals used in that study (reference 7) adhered to McGill University's guidelines for animal husbandry and was approved by the institutional research ethics committee.
###end p 58
###begin title 59
Results
###end title 59
###begin title 60
SHP-1 regulates IRAK-1 kinase activity by direct interaction
###end title 60
###begin p 61
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 263 266 263 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g001">Figure 1</xref>
###xml 398 401 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 501 509 501 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g001">Figure 1</xref>
To investigate the effect of SHP-1 on IRAK-1 kinase activity, we immunoprecipitated IRAK-1 from the lysates of SHP-1-/- MOs and their wildtype (WT) counterparts and subjected the IP to an IRAK-1 kinase assay. Results indicated that IRAK-1 kinase activity in SHP-1-/- cells was significantly higher compared to WT (Figure 1, top panel). The increase in IRAK-1 basal kinase activity observed in SHP-1-/- cells is not due to a differential expression of IRAK-1 as supported by loading controls provided (Figure 1, lower panels).
###end p 61
###begin title 62
Regulation of IRAK-1 kinase activity by SHP-1.
###end title 62
###begin p 63
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 124 129 124 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">me/me</sup>
###xml 119 129 119 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptpn6<sup>me/me</sup></italic>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 244 242 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 380 382 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 504 506 504 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
Upper Panel represents an in vitro kinase assay comparing the basal kinase activity of IRAK-1 in WT littermates versus Ptpn6me/me MO (SHP-1-/-). A fraction of the IP was kept and subjected to a western blot as a control for equal IRAK-1 IP (2nd panel from top). Cell lysates of WT and SHP-1-/- MOs were blotted for SHP-1 to demonstrate the presence/absence of the SHP-1 protein (3rd panel from top). The membrane was stripped and reblotted for IRAK-1 to monitor its expression level in both cell lines (4th panel from top). Actin levels are shown as loading controls (bottom panel). All results are representative of at least three independent experiments.
###end p 63
###begin p 64
###xml 192 201 192 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2A</xref>
###xml 318 327 318 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2B</xref>
###xml 388 397 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2B</xref>
###xml 471 487 471 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figures 2A and B</xref>
###xml 629 637 629 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 860 869 860 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2C</xref>
###xml 426 429 <span type="species:ncbi:10116">rat</span>
Then, to evaluate whether the SHP-1 regulatory effect on IRAK-1's kinase activity involved their interaction, we performed immunoprecipitation assays and observed that IRAK-1 and SHP-1 co-IP (Figure 2A). Their association was further confirmed as we have detected PTP activity corresponding to SHP-1 in the IRAK-1 IP (Figure 2B, top panel), and IRAK-1 kinase activity in the IP of SHP-1 (Figure 2B, bottom panel). A secondary rat antibody was used as a negative control (Figures 2A and B). These experiments suggested the presence of IRAK-1 and SHP-1 in the same multi-protein complex. To test whether they directly interact, we in vitro translated IRAK-1 using radiolabelled methionine, and put the radiolabelled IRAK-1 in contact with GST-SHP-1. IRAK-1 was pulled down specifically by GST-SHP-1 and not by GST alone, showing that this interaction is direct (Figure 2C).
###end p 64
###begin title 65
Demonstration of the IRAK-1/SHP-1 interaction.
###end title 65
###begin p 66
###xml 346 349 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 489 497 489 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 162 168 <span type="species:ncbi:9986">Rabbit</span>
###xml 178 181 <span type="species:ncbi:10116">rat</span>
###xml 271 277 <span type="species:ncbi:9986">Rabbit</span>
###xml 287 290 <span type="species:ncbi:10116">rat</span>
(A) Western blot analysis demonstrating the Co-IP of IRAK-1 and SHP-1. IRAK-1 and SHP-1 were immunoprecipitated then blotted against SHP-1 and IRAK-1 antibodies. Rabbit IgG anti-rat was used as a control. (B) In gel PTP activity assay of SHP-1 and IRAK-1 IPs (top blot). Rabbit IgG anti-rat was used as an IP control. Cell lysates of WT and SHP-1-/- were added in the last two lanes to confirm that the signal was SHP-1. Lower blot represents IRAK-1 kinase activity in reciprocal IPs. (C) In vitro transcription/translation of the IRAK-1 gene was performed using radiolabelled methionine. First lane shows the IRAK-1 input. The last two lanes show methionine-labelled IRAK-1 pulled down after 1 h incubation with either a GST-SHP-1 or GST respectively. (D) Kinase assay measuring IRAK-1 activity upon its interaction with either GST alone or increasing concentrations of an active GST-SHP-1 construct (left panel). Kinase assay measuring IRAK-4 activity (right panel) upon its interaction with either GST alone or GST-SHP-1 (5 microg). (E) Kinase assay showing IRAK-1 activity at basal level and upon LPS treatment subjected to alkali treatment to evaluate tyrosine phosphorylation in IRAK-1. Tyrosyl phosphorylation was confirmed by western blot using an anti-phosphotyrosine antibody. An IP fraction was kept and blotted for IRAK-1 as a loading control.
###end p 66
###begin p 67
###xml 307 328 307 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2D, left panel</xref>
###xml 448 470 448 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2D, right panel</xref>
Next, we examined whether the binding of SHP-1 is sufficient to regulate IRAK-1 kinase activity. To do so, IRAK-1 was immunoprecipitated and put in contact with increasing concentrations of active GST-SHP-1. IRAK-1 kinase activity was inhibited in a dose-dependent manner by GST-SHP-1 and not by GST alone (Figure 2D, left panel). Interestingly, the highest dose of GST-SHP-1 used to inhibit IRAK-1 activity did not alter IRAK-4's kinase activity (Figure 2D, right panel).
###end p 67
###begin p 68
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Kollewe1">[18]</xref>
###xml 690 699 688 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2E</xref>
###xml 806 815 804 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g002">Figure 2E</xref>
The fact that the PTP-SHP-1 dephosphorylates tyrosyl residues raised the possibility that IRAK-1 is tyrosine phosphorylated. To investigate this hypothesis, alkali-resistance phosphoprotein assays were performed. Treatment of IRAK-1 kinase assay gels with KOH permits the in-gel dephosphorylation of pSer and pThr, but not pTyr allowing us to evaluate the contribution of tyrosine phosphorylation to the overall phosphorylation signal. Although IRAK-1 is known to be phosphorylated on Ser/Thr residues [18], our results represent the first demonstration that IRAK-1 is also tyrosine phosphorylated in the resting state, and that LPS increases IRAK-1 tyrosyl phosphorylation by 46+/-15% SD (Figure 2E, upper panels). This finding was further confirmed by western blot using the 4G10 pTyr-specific antibody (Figure 2E, lower two panels).
###end p 68
###begin title 69
SHP-1 binds to the kinase domain of IRAK-1 via an ITIM-like motif
###end title 69
###begin p 70
###xml 160 163 160 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">286</sub>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 165 166 165 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 169 172 169 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">291</sub>
###xml 204 213 204 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000305.s001">Figure S1</xref>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000305.s002">Figure S2</xref>
###xml 548 556 548 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 573 581 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g003">Figure 3</xref>
###xml 1352 1353 1352 1353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
###xml 1359 1360 1359 1360 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1373 1374 1373 1374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1384 1385 1384 1385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</bold>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
At the view of our observations, we screened the mouse IRAK-1 sequence for possible SHP-1 binding sites. We discovered that IRAK-1 contains an ITIM-like motif (286LVYGFL291) located in its kinase domain (Figure S1). This motif was found to be absent in all the other IRAK family members since the last residue is a methionine instead of a leucine (Figure S2). To determine the involvement of this ITIM-like motif in the SHP-1/IRAK-1 binding, we used the full-length IRAK-1 sequence to introduce site-specific mutations within the motif followed by in vitro binding assays (Figure 3). Firstly, a Y288F mutation slightly decreased SHP-1 binding suggesting that possible phosphorylation of the motif's central tyrosine may increase binding affinity but is not absolutely necessary for the binding to occur. Secondly, an L291M mutation, which renders the site no more ITIM-like, significantly decreased SHP-1 binding. Thirdly, the G289A/F290Y/L291M triple mutation, which also disrupts the ITIM-like motif, completely abrogated the binding of SHP-1. Interestingly, this triple mutant of IRAK-1 is identical to the corresponding site within IRAK-4. Collectively, these site-specific mutations confirm the role of the ITIM-like motif in the binding of SHP-1 to IRAK-1. This represents the first description of such a motif in a kinase that we now call KTIM (Kinase Tyrosyl-based Inhibitory Motif). Importantly, these experiments also suggest that the SHP-1-mediated regulation of IRAK-1 is a mechanism not shared with IRAK-4.
###end p 70
###begin title 71
Mutation of IRAK-1's KTIM abrogates its ability to bind SHP-1.
###end title 71
###begin p 72
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 246 254 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Top panel represents methionine-labelled WT-IRAK-1 as well as the different IRAK-1 mutants in vitro translated and put in contact with 5 microg of either GST alone or a trapping GST-SHP-1 construct. Bottom panel represents equal fractions of the in vitro translated products ran on an SDS gel to show equal input. All results are representative of at least three independent experiments.
###end p 72
###begin title 73
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Leishmania inhibits LPS-mediated MO functions by rapidly inactivating IRAK-1
###end title 73
###begin p 74
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Powers1">[19]</xref>
###xml 252 255 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 361 364 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget2">[7]</xref>
###xml 365 368 361 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Massa1">[9]</xref>
###xml 452 455 448 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget3">[8]</xref>
###xml 544 553 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g004">Figure 4A</xref>
###xml 621 624 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 685 694 681 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g004">Figure 4B</xref>
The biological relevance of this regulatory interaction between IRAK-1 and SHP-1 was investigated using the ability of N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole, a potent IRAK-1 inhibitor [19], to reduce NO production in WT and SHP-1-/- MOs. As mentioned earlier, SHP-1 deficiency in MOs results in an increase in NF-kappaB and AP-1 activity [7]-[9] leading to NO production at basal level and in response to LPS when compared to WT [8]. Addition of the IRAK-1 inhibitor abrogated IRAK-1 activity in a dose-dependent manner (Figure 4A), and was paralleled by a reduction of basal NO production in SHP-1-/- cells and in LPS-mediated NO production in both cell lines (Figure 4B). In addition to demonstrating the essential role of IRAK-1 signalling in NO generation, our data also shows that SHP-1-mediated IRAK-1 regulation is critical for the control of MO activation.
###end p 74
###begin title 75
Effect of pharmacological inhibition of IRAK-1 on MO NO production.
###end title 75
###begin p 76
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 459 462 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(A) IRAK-1 was immunoprecipitated from SHP-1-/- MO lysates and incubated (1 h, RT) with increasing concentrations of the IRAK-1 inhibitor. A kinase assay was then performed to show functionality of the inhibitor. Data are representative of three experiments. (B) NO assay showing that the IRAK-1 inhibitor blocks, in a dose-dependent manner, basal production of NO by SHP-1-/- cells as well as LPS-mediated (O/N stimulation) NO production in both WT and SHP-1-/- MOs.
###end p 76
###begin p 77
###xml 6 16 6 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 208 218 208 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g005">Figure 5A</xref>
###xml 316 325 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g005">Figure 5B</xref>
###xml 347 356 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g005">Figure 5C</xref>
Using Leishmania as an infectious model, we studied its ability to inhibit key MO LPS-mediated functions namely: IL-12 expression, TNF production, and NO generation. Our results confirmed that infection with Leishmania caused a significant inhibition of LPS-mediated expression of IL-12 (Figure 5A), TNF production (Figure 5B), and NO generation (Figure 5C) in MOs.
###end p 77
###begin title 78
###xml 40 50 40 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Inhibition of LPS-mediated functions by Leishmania.
###end title 78
###begin p 79
###xml 83 93 83 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 133 144 133 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 256 266 256 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 356 366 356 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 133 144 <span type="species:ncbi:5661">L. donovani</span>
(A) LPS-mediated MO IL-12 mRNA expression was analyzed by RT-PCR in uninfected and Leishmania-infected MOs. Cells were infected with L. donovani O/N followed by LPS stimulation (10 and 100 ng/ml, 12 h). (B) LPS-mediated TNF production by MOs infected with Leishmania. Cells have been infected as above and stimulated with LPS for 3 h. (C) NO production by Leishmania-infected MOs in response to LPS. Cells have been infected as above and stimulated with LPS for 24 h. (A-C) *, significant at P<0.05, Anova test, error bar SEM. Mean of three independent experiments.
###end p 79
###begin p 80
###xml 3 13 3 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 152 162 152 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 244 255 244 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g006">Figure 6A</xref>
###xml 517 527 517 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 576 586 576 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 650 661 650 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 741 752 739 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. mexicana</italic>
###xml 757 765 755 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 887 896 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g006">Figure 6B</xref>
###xml 914 927 908 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. tarentolae</italic>
###xml 953 963 947 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 244 255 <span type="species:ncbi:5661">L. donovani</span>
###xml 650 661 <span type="species:ncbi:5661">L. donovani</span>
###xml 741 752 <span type="species:ncbi:5665">L. mexicana</span>
###xml 757 765 <span type="species:ncbi:5664|species:ncbi:419269|species:ncbi:55468|species:ncbi:488399|species:ncbi:225018">L. major</span>
###xml 914 927 <span type="species:ncbi:5689">L. tarentolae</span>
As Leishmania activates host SHP-1 and blocks many LPS-mediated functions known to be detrimental to the parasite, we investigated the possibility that Leishmania inactivates IRAK-1. Kinase assays comparing IRAK-1 activity in MOs infected with L. donovani to uninfected cells revealed that the parasite caused a rapid time-dependent inactivation of IRAK-1 seen by reduced basal IRAK-1 activity in infected MOs (Figure 6A). To investigate whether IRAK-1 inactivation is a common mechanism utilized by other infectious Leishmania species, MOs were infected for 1 h with various Leishmania species promastigotes and IRAK-1 kinase activity was measured. L. donovani decreased IRAK-1 activity by 65+/-11% SD, and consistent with our expectation, L. mexicana and L. major were also able to inactivate IRAK-1 as they decreased IRAK-1 kinase activity by 65+/-7% SD and 52+/-4% SD, respectively (Figure 6B). Interestingly, L. tarentolae, a lizard non-pathogenic Leishmania did not inhibit IRAK-1 and seemed to even slightly activate it (increase of 20+/-11% SD).
###end p 80
###begin title 81
###xml 52 62 52 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Inhibition of LPS-induced IRAK-1 kinase activity by Leishmania.
###end title 81
###begin p 82
###xml 90 101 90 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 276 286 276 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 296 330 296 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani, L. mexicana, L. major</italic>
###xml 390 403 390 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. tarentolae</italic>
###xml 491 502 491 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 638 649 638 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 90 101 <span type="species:ncbi:5661">L. donovani</span>
###xml 296 307 <span type="species:ncbi:5661">L. donovani</span>
###xml 309 320 <span type="species:ncbi:5665">L. mexicana</span>
###xml 322 330 <span type="species:ncbi:5664|species:ncbi:419269|species:ncbi:55468|species:ncbi:488399|species:ncbi:225018">L. major</span>
###xml 390 403 <span type="species:ncbi:5689">L. tarentolae</span>
###xml 491 502 <span type="species:ncbi:5661">L. donovani</span>
###xml 638 649 <span type="species:ncbi:5661">L. donovani</span>
(A) Kinase assay performed on IRAK-1 IPs from lysates of MOs uninfected and infected with L. donovani over a 6 h time-period. LPS stimulation (100 ng/ml, 30 min), positive control. (B) IRAK-1 kinase activity detected in IPs from lysates of MOs infected or not with pathogenic Leishmania species (L. donovani, L. mexicana, L. major) (20:1 parasite to cell ratio, 1 h). Non-pathogenic lizard L. tarentolae was used as negative control. (C) Kinase assay of IRAK-1 IPs from lysates of naive and L. donovani-infected MOs (O/N infection) subjected or not to LPS stimulation (100 ng/ml, 30 min). (D) IRAK-1 kinase activity in IPs from naive and L. donovani-infected MOs (O/N infection) stimulated or not with various TLR ligands (MALP (100 ng/ml), LPS (100 ng/ml), flagellin (100 ng/ml), CpG (5 microg/ml); 30 min). All results are representative of at least three independent experiments.
###end p 82
###begin p 83
###xml 75 85 75 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 269 279 269 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 340 349 340 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g006">Figure 6C</xref>
###xml 453 463 453 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 560 570 560 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 660 669 660 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g006">Figure 6D</xref>
###xml 744 754 744 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 919 928 915 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000305.s003">Figure S3</xref>
In light of these observations, we were interested to evaluate whether the Leishmania-mediated IRAK-1 kinase inactivation could alter LPS-mediated functions in infected MOs. Our results indicated that unlike LPS stimulation per se that activates IRAK-1, infection with Leishmania rendered IRAK-1 activation refractory to this TLR4 agonist (Figure 6C). Since IRAK-1 signals downstream of all TLRs with the exception of TLR3, we investigated whether this Leishmania-induced IRAK-1 inactivation is persistent upon stimulation with other TLR ligands. As expected, Leishmania was able to render IRAK-1 unresponsive to MALP (TLR2), flagellin (TLR5), and CpG (TLR9) (Figure 6D). These results suggest that alteration of IRAK-1-dependent signalling by Leishmania causes a general unresponsiveness to a broad range of TLR ligands. All TLR ligands used were shown to be functional using an NF-kappaB nuclear translocation assay (Figure S3).
###end p 83
###begin title 84
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Leishmania infection enhances the IRAK-1/SHP-1 interaction leading to IRAK-1 inactivation
###end title 84
###begin p 85
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Forget3">[8]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Blanchette1">[20]</xref>
###xml 154 164 154 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 383 393 383 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 405 414 405 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g007">Figure 7A</xref>
###xml 524 534 524 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g007">Figure 7B</xref>
###xml 586 596 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 700 709 700 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g007">Figure 7C</xref>
Having previously reported that Leishmania can rapidly induce host PTP SHP-1 to inactivate JAK and MAP kinase pathways [8],[20], we hypothesized that the Leishmania-induced IRAK-1 inactivation observed was associated with an increased SHP-1/IRAK-1 interaction. We indeed noticed by Western blot that a significantly greater amount of SHP-1 was co-immunoprecipitated with IRAK-1 upon Leishmania infection (Figure 7A). Similarly, using in gel PTP assay, we were able to detect more SHP-1 activity in IRAK-1 IP from lysates of Leishmania-infected MOs (Figure 7B). Higher SHP-1 activity in Leishmania infected MOs was further supported when equal IP fractions were subjected to a pNPP phosphatase assay (Figure 7C).
###end p 85
###begin title 86
###xml 40 50 40 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
IRAK-1/SHP-1 interaction is enhanced by Leishmania infection and leads to IRAK-1 signalling alteration and MO functional inhibition.
###end title 86
###begin p 87
###xml 94 104 94 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 166 176 166 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 520 530 520 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 745 755 745 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 807 808 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 919 922 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 948 959 948 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1121 1131 1121 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1153 1156 1153 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1211 1222 1211 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1286 1287 1286 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1393 1403 1393 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1475 1485 1475 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1640 1651 1640 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 948 959 <span type="species:ncbi:5661">L. donovani</span>
###xml 1211 1222 <span type="species:ncbi:5661">L. donovani</span>
###xml 1640 1651 <span type="species:ncbi:5661">L. donovani</span>
(A) Western blot analysis demonstrating the enhanced co-IP of IRAK-1 and SHP-1 in response to Leishmania infection. IRAK-1 was immunoprecipitated from uninfected and Leishmania-infected MO lysates (30 min post-infection). The IPs were run on SDS-PAGE and blotted against SHP-1 (upper panel). Membrane was then stripped and blotted against IRAK-1 as a control for equal IP (lower panel). (B) A fraction of the IPs (a, upper panel) was subjected to in gel PTP assay showing higher SHP-1 activity associated with the IP of Leishmania-infected MOs over uninfected. (C) Fraction of the IP (a, upper panel) was also subjected to a phosphatase assay based on pNPP hydrolysis demonstrating a significantly higher total phosphatase activity in the IP of Leishmania-infected cells compared to uninfected controls. *, P<0.05; error bar SD. Data are the mean of four independent experiments. (D) IRAK-1 kinase assay of WT and SHP-1-/- MOs infected or not with L. donovani for 1 h (upper panel). IP fraction was kept and subjected to western blot as a loading control of IRAK-1 immunoprecipitation (lower panel). (E) NO production by Leishmania-infected WT and SHP-1-/- MOs in response to LPS. Cells have been infected with L. donovani (O/N) and stimulated with LPS for 24 h. Significant difference P<0.05, Anova test, error bar SEM. Mean of three independent experiments. (F and G) IRAK-1 Inactivation by Leishmania causes its inability to bind TRAF6. Western blot analysis showing that Leishmania causes an abrogation of the ability of IRAK-1 to bind TRAF6, but not MyD88, upon LPS stimulation. IRAK-1 was immunoprecipitated from lysates of naive and L. donovani-infected MO (1 h infection) stimulated or not with LPS (100 ng/ml, 1 h). The IPs were run on SDS-PAGE and blotted against MyD88 (F) and TRAF6 (G). Membranes were stripped and blotted against IRAK-1 to demonstrate equal IP.
###end p 87
###begin p 88
###xml 60 70 60 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g006">Figure 6</xref>
###xml 246 256 246 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 359 370 357 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania-</italic>
###xml 473 482 469 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g007">Figure 7D</xref>
###xml 608 611 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 617 626 613 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g007">Figure 7E</xref>
###xml 675 685 671 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
To demonstrate that the increased SHP-1/IRAK-1 binding upon Leishmania infection is responsible for IRAK-1 inactivation, IRAK-1 kinase activity was monitored in infected WT and SHP-1-/- MOs. In accordance with our finding in B10R MOs (Figure 6), Leishmania was able to inactivate IRAK-1 in WT MOs (67+/-9% SD decrease in IRAK-1 activity). Interestingly, this Leishmania-induced inactivation was not detected in the absence of SHP-1 (2+/-6% SD decrease in IRAK-1 activity) (Figure 7D). This rescue of IRAK-1 activity was correlated with an inability of the parasite to block LPS-induced NO production in SHP-1-/- MOs (Figure 7E). Collectively, this set of data shows that the Leishmania-activated SHP-1 is responsible for IRAK-1 inactivation leading to the unresponsiveness of infected MOs to LPS stimulation.
###end p 88
###begin p 89
###xml 246 256 246 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 319 329 319 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 460 476 460 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g007">Figures 7F and G</xref>
To further understand the impact of IRAK-1 inactivation on LPS-mediated activation in infected MOs, we monitored the association and dissociation events of IRAK-1 with known key signalling molecules (MyD88, TRAF6) in response to LPS in naive and Leishmania-infected cells. The result showed that IRAK-1 inactivation by Leishmania-induced SHP-1 is associated with the inability of IRAK-1 to detach from MyD88 and attach to TRAF6 in response to LPS stimulation (Figures 7F and G).
###end p 89
###begin title 90
IRAK-1 and SHP-1 emerged in early vertebrates while IRAK-1 KTIM appeared only in amphibians
###end title 90
###begin p 91
###xml 132 141 132 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 213 214 213 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 215 216 215 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</bold>
###xml 218 219 218 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 264 272 264 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g008">Figure 8</xref>
###xml 302 320 302 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 388 389 388 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 389 390 389 390 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 390 391 390 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</bold>
###xml 391 393 391 393 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LY</underline>
###xml 393 394 393 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</bold>
###xml 482 483 482 483 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</bold>
###xml 483 484 483 484 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 484 485 484 485 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</bold>
###xml 485 488 485 488 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VYM</underline>
###xml 685 694 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000305.s004">Figure S4</xref>
###xml 759 768 759 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g009">Figure 9A</xref>
###xml 999 1008 999 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g009">Figure 9B</xref>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 302 320 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 414 423 <span type="species:ncbi:7955">zebrafish</span>
###xml 987 996 <span type="species:ncbi:7955">zebrafish</span>
Given the important regulatory function of the KTIM present within IRAK-1, we speculated that it would be evolutionarily conserved. In silico sequence comparisons of available IRAK-1 sequences revealed that KTIM (LVYGFL) was fully conserved from rodents to human (Figure 8). However, while the KTIM in Xenopus tropicalis showed some variations compared to the other vertebrate sequences (LIYLYL), it was absent in zebrafish due to the presence of a methionine at the last position (VIYVYM). Next, we addressed the origin of IRAK-1 and SHP-1 as they are only present in vertebrates. Sequence similarity analyses, including available IRAK-4 sequences from vertebrates and invertebrates (Figure S4), indicate that IRAK-1 evolved from IRAK-4 by gene duplication (Figure 9A). Similar sequence similarity comparisons suggest that SHP-1 evolved from SHP-2 and its orthologues found in invertebrates and that the ancestral SHP-1 gene also appeared through gene duplication in lower vertebrates (zebrafish) (Figure 9B).
###end p 91
###begin title 92
IRAK-1 KTIM is evolutionarily conserved in vertebrates.
###end title 92
###begin p 93
###xml 114 132 114 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 162 173 162 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 283 295 283 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 309 324 309 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 331 347 331 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis familiaris</italic>
###xml 355 365 355 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bos Taurus</italic>
###xml 374 386 374 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 393 410 393 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 114 132 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 162 173 <span type="species:ncbi:7955">Danio rerio</span>
###xml 175 184 <span type="species:ncbi:7955">zebrafish</span>
###xml 238 243 <span type="species:ncbi:9606">human</span>
###xml 276 281 <span type="species:ncbi:9606">Human</span>
###xml 283 295 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 297 307 <span type="species:ncbi:9598">Chimpanzee</span>
###xml 309 324 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 326 329 <span type="species:ncbi:9615">Dog</span>
###xml 331 347 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 367 372 <span type="species:ncbi:10090">Mouse</span>
###xml 374 386 <span type="species:ncbi:10090">Mus musculus</span>
###xml 388 391 <span type="species:ncbi:10116">Rat</span>
###xml 393 410 <span type="species:ncbi:10116">Rattus norvegicus</span>
Sequence comparison of IRAK-1 in various vertebrates reveal that the KTIM is conserved in all vertebrates down to Xenopus tropicalis (amphibian) but is absent in Danio rerio (zebrafish). All homology percentages were calculated using the human IRAK-1 sequence as a reference. Human: Homo sapiens; Chimpanzee: Pan troglodytes; Dog: Canis familiaris; Bull: Bos Taurus; Mouse: Mus musculus; Rat: Rattus norvegicus.
###end p 93
###begin title 94
Evolution of vertebrate IRAK-1 and SHP-1 from IRAK-4 and SHP-2 ancestor genes.
###end title 94
###begin p 95
###xml 335 340 <span type="species:ncbi:10090">mouse</span>
Schematic representation of the appearance of IRAK-1 and SHP-1 from gene duplication events of the IRAK-4 (A) and SHP-2 (B) ancestor genes, respectively. The emergence of the KTIM in IRAK-1 occurred after this gene duplication event took place as the motif only appeared in amphibians. Similarity percentages were calculated using the mouse IRAK-1 and IRAK-4 sequences.
###end p 95
###begin p 96
###xml 519 529 512 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g010">Figure 10A</xref>
###xml 983 993 973 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g010">Figure 10B</xref>
From these observations, we raised the question whether other kinases may also have a KTIM within their kinase domain. Although several proteins involved in MyD88-dependent signalling (e.g. MyD88, TIRAP, TRAF6) did not contain KTIMs in their amino acid sequence (data not shown), we were intrigued to discover that several kinases from the JAK, MAP, Src, and IKK kinase families (JAK2, JAK3, Erk1/2, JNK, p38, Lyn, IKKalpha/beta) contained one or more potential KTIMs, the majority located within their kinase domains (Figure 10A). This finding raises the possibility that KTIMs play important regulatory functions for many kinases by favoring their interaction with SHP-1, as we herein report for IRAK-1. SHP-1 binding may control the activity of these kinases at resting state or regulate their activity upon activation. In gel phosphatase assays that we performed support this possibility as they demonstrate that IPs of IKK-beta, Erk, JNK, and p38 indeed exhibit SHP-1 activity (Figure 10B), indicating that these kinases interact with SHP-1. Interestingly, Syk - a kinase that has no KTIM in its amino acid sequence - did not show interaction with SHP-1 at resting state.
###end p 96
###begin title 97
Several kinases possess KTIMs.
###end title 97
###begin p 98
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 448 454 <span type="species:ncbi:9986">rabbit</span>
(A) Table showing that several kinases from the JAK, MAP, Src, and IKK kinase families possess potential KTIMs in their amino acid sequences. Screening was done using published mouse protein sequences found in the NCBI protein database. (B) An in gel phosphatase assay (upper panel) demonstrating that IPs of IKK-beta, Erk1/2, JNK, and p38 all exhibit SHP-1 activity. Syk IP was added as a control for a kinase that has no KTIM in its sequence and rabbit IgG was used as a negative control. Fractions of all IPs were kept and run on SDS-PAGE and blotted against their corresponding antibody to demonstrate the success of the IP procedure (lower panel).
###end p 98
###begin title 99
Discussion
###end title 99
###begin p 100
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 149 152 149 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier1">[2]</xref>
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Cameron1">[4]</xref>
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Carrera1">[5]</xref>
###xml 209 219 209 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 269 272 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier1">[2]</xref>
###xml 397 407 393 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 487 497 483 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
Leishmania has been reported to inhibit critical LPS-mediated MO functions such as NO and pro-inflammatory cytokines (e.g. IL-12 and TNF) production [2],[4],[5]. Although mechanisms whereby NO is inhibited by Leishmania in response to IFN-gamma have been well explored [2], our knowledge concerning the negative regulatory mechanisms leading to the down-regulation of LPS-mediated MO functions in Leishmania-infected cells is limited. Herein, we provide the first demonstration that the Leishmania parasite can rapidly inactivate IRAK-1 kinase activity with the participation of SHP-1, therefore inhibiting MO LPS-mediated functions. We further reveal that the mechanism by which this inactivation occurs is through the binding of SHP-1 to an evolutionarily-conserved ITIM-like motif located in the kinase domain of IRAK-1. This is the first demonstration that a pathogen can use a host PTP to inactivate IRAK-1 and therefore block signalling pathways ultimately leading to free radicals and pro-inflammatory cytokines production known to be detrimental to its survival.
###end p 100
###begin p 101
###xml 172 182 172 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 284 287 284 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Olivier1">[2]</xref>
###xml 300 310 300 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Proudfoot1">[21]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Feng1">[22]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Piedrafita1">[23]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Weinheber1">[24]</xref>
###xml 587 597 587 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Feng1">[22]</xref>
###xml 689 693 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Weinheber1">[24]</xref>
###xml 766 776 762 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 865 875 861 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 960 970 956 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1079 1089 1075 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1431 1441 1427 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1642 1652 1638 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1729 1730 1725 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 1732 1740 1728 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">donovani</italic>
###xml 1799 1803 1791 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Flandin1">[25]</xref>
###xml 1962 1972 1954 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 2121 2124 2113 2116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2143 2153 2135 2145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 2256 2259 2248 2251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2319 2329 2311 2321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1729 1740 <span type="species:ncbi:5661">L. donovani</span>
Given that TNF is a potent MO activator, NO is leishmanicidal, and IL-12 is a critical cytokine that drives Th1 responses essential for the development of immunity against Leishmania, it is not surprising that the parasite has evolved means to block the production of these molecules [2]. A role for Leishmania phosphoglycans (PG) has been proposed in the inhibition of NO [21]. In addition, roles for promastigote PG [22],[23] and amastigote cysteine peptidases [24] in the inhibition of LPS-mediated IL-12 production have been reported. Nevertheless, apart from very few reports about Leishmania-induced alterations in the Erk MAPK [22] and the downstream transcription factor NF-kappaB [24], very little is known about how LPS-mediated functions are inhibited by Leishmania. In this study, we confirmed that all three LPS-mediated MO functions were inhibited by Leishmania. Importantly, looking at NO production as a key function involved in the killing of Leishmania parasites, we were able to show that IRAK-1 signalling is key for its production. In fact, our finding that Leishmania inactivates IRAK-1 kinase activity and that this inactivation is persistent upon subsequent LPS-stimulation supports the fact that the parasite is able to successfully block LPS-mediated NO production in MOs. Interestingly, consistent with the fact that IRAK-1 signals downstream of many TLRs, we showed that IRAK-1 was also unresponsive in Leishmania-infected cells subjected to stimulation with TLR2, TLR5, and TLR9 ligands. This result suggests that the parasite causes wide range unresponsiveness to TLR signalling upon infection possibly allowing Leishmania to avoid any harmful MO activation involving TLR engagement. Interestingly, L. donovani has been shown to activate IRAK-1 in IFN-gamma-primed MOs [25] suggesting that the activation state of the MO can play an important role in the ability of the parasite to inactivate IRAK-1. In an effort to understand how Leishmania inactivates IRAK-1, we were able to identify SHP-1 as a key player in this process as there was almost a complete rescue of IRAK-1 activity in SHP-1-/- MOs infected with Leishmania. This rescue was corroborated by the parasite's inability to block LPS-mediated NO production in SHP-1-/- MOs. These results suggest a new evasion mechanism whereby Leishmania can avoid detrimental MO functions driven by MyD88-dependent pathways by blocking IRAK-1, a key kinase in this pathway.
###end p 101
###begin p 102
###xml 25 35 25 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-An1">[11]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Kollewe1">[18]</xref>
Our observation that the Leishmania-mediated IRAK-1 inactivation was associated with enhanced SHP-1 binding to IRAK-1 fits with our finding that SHP-1 binds to and regulates IRAK-1 at resting state. We clearly showed that IRAK-1's intrinsic kinase activity was higher in SHP-1-/- compared to WT MOs identifying SHP-1 as a novel regulator of IRAK-1 activity, a finding supported by recent work of Cao and colleagues [11]. The fact that SHP-1 interacts with and also dephosphorylates tyrosyl residues raised the possibility that IRAK-1 is tyrosine phosphorylated. Here, we show that IRAK-1 is indeed tyrosine phosphorylated at resting state, and further so in response to LPS stimulation. Given that IRAK-1 was previously shown to be phosphorylated on Ser/Thr residues only [18], our findings represent the first demonstration that IRAK-1 is also tyrosine phosphorylated.
###end p 102
###begin p 103
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Avril1">[26]</xref>
###xml 1345 1349 1345 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Staub1">[27]</xref>
###xml 1525 1526 1525 1526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</bold>
###xml 1532 1533 1532 1533 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</bold>
###xml 1546 1547 1546 1547 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</bold>
###xml 1557 1558 1557 1558 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</bold>
Having identified an ITIM-like motif in the kinase domain of IRAK-1 as the binding site of SHP-1, its functionality was demonstrated by generating mutations within the motif providing valuable information about the role of its amino acid components in the binding affinity of SHP-1. Firstly, the tyrosine to phenylalanine (Y288F) mutation suggested that the phosphorylation of the motif's central tyrosine is not necessary for the binding of SHP-1 to occur. Indeed it has been previously reported that tyrosyl phosphorylation within ITIMs is not always required for the binding of SH2-domain containing proteins [26]. Secondly, the observation that the G289A-F290Y-L291M mutation caused a total abrogation of SHP-1 binding, and that the L291M mutation partially reduced binding suggested that the amino acids between the central tyrosine and the terminal leucine in the motif play an important role in the binding affinity of SHP-1. Lastly, as the triple mutant was designed to render the ITIM-like site in IRAK-1 identical to its corresponding site in IRAK-4, the loss of SHP-1 binding in this mutant suggested that the SHP-1-mediated regulation of IRAK-1 is a regulatory mechanism not shared with IRAK-4. It is noteworthy to emphasize that ITIMs have been named so due to their presence in intracytoplasmic portions of transmembrane receptors [27]. Given that here we describe this motif to be found in a cytosolic kinase and show that it mediates SHP-1 binding and IRAK-1negative regulation, we propose to rename it KTIM (Kinase Tyrosyl-based Inhibitory Motif).
###end p 103
###begin p 104
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Takeda1">[1]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Kollewe1">[18]</xref>
###xml 599 609 599 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 802 812 802 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 1210 1221 1210 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania-</italic>
In MyD88-dependent signalling pathways, binding of TLR ligand to its corresponding receptor causes a rearrangement of the receptor complex and triggers the recruitment of the adaptor protein MyD88, which in turn recruits the kinases IRAK-4 and IRAK-1 to the receptor complex [1]. Upon critical phosphorylations of IRAK-1 by IRAK-4 [18], IRAK-1 is partially activated and is able to get fully activated by autophosphorylation. This autophosphorylation causes IRAK-1 to detach from the MyD88 complex and attach to TRAF6 activating downstream signalling pathways. Therefore, the IRAK-1 inactivation by Leishmania-induced SHP-1 had to interfere somehow with the integrity of the previous signalling events. Of utmost interest, we have been able to show that although IRAK-1 was still able to bind MyD88 in Leishmania-infected MOs in response to LPS stimulation, the kinase was unable to detach from the MyD88 complex and bind to TRAF6 as the stimulation persisted. This is the first demonstration that a pathogen can interfere with Toll signalling by altering IRAK-1's capacity to dissociate from the MyD88 complex. This inability of IRAK-1 to detach from MyD88 is supported by our observation that the binding of Leishmania-induced SHP-1 to the kinase domain of IRAK-1 causes a strong inactivation of this kinase seen by its inability to autophosphorylate, a process required for IRAK-1 to detach from the receptor complex and activate downstream signalling cascades.
###end p 104
###begin p 105
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000305.s005">Figure S5</xref>
###xml 651 660 651 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pntd.0000305.s005">Figure S5</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Mushegian1">[28]</xref>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Neel1">[29]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Li1">[30]</xref>
###xml 1364 1368 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Bedecs1">[31]</xref>
###xml 1369 1373 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000305-Matsubara1">[33]</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Finally, it was remarkable to find out that the KTIM in IRAK-1 was evolutionarily conserved from human to rodents. The absence of KTIM in fish and its appearance in amphibians suggests that this motif emerged rapidly after the appearance of the ancestral IRAK-1 gene in early branching vertebrates (amphibians) and was highly conserved thereafter (Figure S5). Our findings thus raise the possibility that during the course of evolution, the emergence of a mechanism to regulate the innate immune response by targeting IRAK-1 activity (e.g. SHP-1) may have favoured the development of a more sophisticated adaptive immune system in higher vertebrates (Figure S5). In addition, it is important to note that Toll-Interacting Protein (TOLLIP) [28], the only other negative regulator of IRAK-1 in the resting state has emerged very early in invertebrates as opposed to SHP-1 [29], IRAK-1 [30] and the KTIM motif which all appeared only in early vertebrates. Noteworthy, we found that several other kinases from the JAK, MAP and IKK kinase families contained one or more potential KTIMs raising the possibility that KTIMs play important regulatory functions in many kinases (other than IRAK-1) by favouring their interaction with SHP-1. In fact, it has been previously reported that some of these kinases (e.g. JAK2, JAK3, JNK, Erk1/2) are negatively regulated by SHP-1 [31]-[33]. However, none of these studies paid great attention to the mechanism whereby SHP-1 either interacts or regulates these kinases. It remains to be mentioned that whereas some of these kinases are also present in invertebrates, IRAK-1 and its KTIM only appeared in vertebrates. This observation supports the idea that the appearance of this motif in IRAK-1 has favoured the development of a mechanism to control the innate immune response. In this context, regulation of IRAK-1 kinase activity would have prevented abnormal and exacerbated microbicidal and inflammatory immune responses that could have been detrimental to vertebrates and to the development of the adaptive immune response. It is also tempting to speculate that the appearance of an improved control over kinases by SHP-1 may have influenced the global development of vertebrates, as several of these kinases play pivotal roles in the regulation of cellular, molecular, developmental, and metabolic processes.
###end p 105
###begin p 106
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 356 366 356 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
###xml 577 587 577 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania</italic>
In conclusion, we have identified a new evasion mechanism whereby Leishmania-activated SHP-1 binds to an evolutionarily conserved KTIM located in IRAK-1's kinase domain leading to its inactivation. This abrogation was associated with the inability of IRAK-1 to detach from the MyD88 complex to bind TRAF6, consequently resulting in the unresponsiveness of Leishmania-infected macrophages to several TLR ligand stimulation including LPS. By doing so, the parasite is not only able to block LPS-mediated MO production of NO and pro-inflammatory cytokines known to be involved in Leishmania killing, but also terminate the extremely important roles played by these molecules in the development of an effective adaptive immune response. At the evolutionary level, we propose that the appearance of SHP-1 as a key regulator of IRAK-1 kinase activity represented a pivotal evolutionary step that could have favoured the development of the adaptive immune response in vertebrates.
###end p 106
###begin title 107
Supporting Information
###end title 107
###begin p 108
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
IRAK-1 contains a KTIM motif in its kinase domain. The full amino acid sequence of mouse IRAK-1 has been obtained from the NCBI protein database (Ref. no. Q62406). The newly identified KTIM is in violet. Bottom drawing is a schematic representation of the IRAK-1 protein showing the locations of the different domains and critical residues. KTIM motif is shown as a violet rectangle. ProST, Proline/Serine/Threonine -rich.
###end p 108
###begin p 109
(1.56 MB TIF)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
###xml 292 297 <span type="species:ncbi:10090">Mouse</span>
Among the IRAK family, KTIM is unique to IRAK-1. All other IRAK family members (IRAK-2, IRAK-M, and IRAK-4) whose sequences are available for various invertebrate and vertebrate organisms lack a KTIM. A sequence comparison in the KTIM region among the different IRAK family members is shown. Mouse was chosen as a representative organism.
###end p 111
###begin p 112
(0.38 MB TIF)
###end p 112
###begin p 113
Click here for additional data file.
###end p 113
###begin p 114
###xml 215 224 207 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000305-g006">Figure 6D</xref>
TLR ligands activate NF-kappaB in stimulated MOs. Gel represents an electromobility shift assay (EMSA) showing NF-kappaB nuclear translocation in response to a 2 h stimulation with the different TLR ligands used in Figure 6D. The EMSA confirms that the ligands are functional and activating at the concentrations used. MALP, Macrophage-activating lipopeptide-2. Flag, Flagellin. S, Specific competition (100x cold oligo). NS, Non-specific competition (SP1 oligo).
###end p 114
###begin p 115
(0.19 MB TIF)
###end p 115
###begin p 116
Click here for additional data file.
###end p 116
###begin p 117
###xml 447 461 447 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 472 485 472 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gallus gallus</italic>
###xml 494 511 494 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Euprymna scolopes</italic>
###xml 525 554 525 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Strongylocentrotus purpuratus</italic>
###xml 562 584 562 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 596 610 596 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apis mellifera</italic>
###xml 617 640 617 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 432 445 <span type="species:ncbi:9544">Rhesus monkey</span>
###xml 447 461 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 463 470 <span type="species:ncbi:9031">Chicken</span>
###xml 472 485 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 494 511 <span type="species:ncbi:6613">Euprymna scolopes</span>
###xml 525 554 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
###xml 562 584 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 586 594 <span type="species:ncbi:7460">Honeybee</span>
###xml 596 610 <span type="species:ncbi:7460">Apis mellifera</span>
###xml 617 640 <span type="species:ncbi:7227">Drosophila melanogaster</span>
IRAK-4 shows homology to IRAK-1 but does not bear a KTIM due to a single amino acid substitution. IRAK-4 sequence comparison of various vertebrates and invertebrates reveal that IRAK-4 has no KTIM due to a single leucine to methionine/isoleucine substitution. All IRAK-4 homology percentages were calculated using the human IRAK-4 sequence as a reference. IRAK-1/IRAK-4 homology percentages were calculated within the same species. Rhesus monkey: Macaca mulatta; Chicken: Gallus gallus; Squid: Euprymna scolopes; Sea urchin: Strongylocentrotus purpuratus; Worm: Caenorhabditis elegans; Honeybee: Apis mellifera; Fly: Drosophila melanogaster.
###end p 117
###begin p 118
(1.72 MB TIF)
###end p 118
###begin p 119
Click here for additional data file.
###end p 119
###begin p 120
Regulation of IRAK-1 by SHP-1 through its binding to KTIM is unique to vertebrates and may have favoured the development of their adaptive immune response. Schematic representation of the emergence of IRAK-1 and SHP-1 from IRAK-4 and SHP-2, respectively. Unlike TOLLIP and SHP-2 which are found in invertebrates, SHP-1 arose in vertebrates just like IRAK-1 and KTIM, coinciding with the emergence of the adaptive immune response.
###end p 120
###begin p 121
(1.54 MB TIF)
###end p 121
###begin p 122
Click here for additional data file.
###end p 122
###begin p 123
Translation of the Abstract into Arabic by Issa Ayoub Abu-Dayyeh
###end p 123
###begin p 124
(0.02 MB DOC)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin p 126
Translation of the Abstract into French by Marceline Cote
###end p 126
###begin p 127
(0.02 MB DOC)
###end p 127
###begin p 128
Click here for additional data file.
###end p 128
###begin p 129
Translation of the Abstract into Spanish by Maria-Adelaida Gomez and Irazu Contreras
###end p 129
###begin p 130
(0.02 MB DOC)
###end p 130
###begin p 131
Click here for additional data file.
###end p 131
###begin p 132
Translation of the Abstract into Farsi (Persian) by Kasra Hassani
###end p 132
###begin p 133
(0.02 MB DOC)
###end p 133
###begin p 134
Click here for additional data file.
###end p 134
###begin title 135
References
###end title 135
###begin article-title 136
Roles of Toll-like receptors in innate immune responses.
###end article-title 136
###begin article-title 137
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.
###end article-title 137
###begin article-title 138
Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1.
###end article-title 138
###begin article-title 139
###xml 72 91 <span type="species:ncbi:5665">Leishmania mexicana</span>
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.
###end article-title 139
###begin article-title 140
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.
###end article-title 140
###begin article-title 141
The negative regulation of Toll-like receptor and associated pathways.
###end article-title 141
###begin article-title 142
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis.
###end article-title 142
###begin article-title 143
###xml 51 70 <span type="species:ncbi:5661">Leishmania donovani</span>
Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production.
###end article-title 143
###begin article-title 144
Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1.
###end article-title 144
###begin article-title 145
###xml 37 42 <span type="species:ncbi:9606">human</span>
Protein tyrosine phosphatases in the human genome.
###end article-title 145
###begin article-title 146
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1.
###end article-title 146
###begin article-title 147
Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines.
###end article-title 147
###begin article-title 148
###xml 115 121 <span type="species:ncbi:10090">murine</span>
Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression.
###end article-title 148
###begin article-title 149
Investigation of protein-tyrosine phosphatases by in-gel assays.
###end article-title 149
###begin article-title 150
Enhancement of the detection of alkali-resistant phosphoproteins in polyacrylamide gels.
###end article-title 150
###begin article-title 151
###xml 0 19 <span type="species:ncbi:2094">Mycoplasma arginini</span>
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Mycoplasma arginini enhances cytotoxicity of thioglycollate-elicited murine macrophages toward YAC-1 tumor cells through production of NO.
###end article-title 151
###begin article-title 152
###xml 26 32 <span type="species:ncbi:10090">murine</span>
Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase- and cyclic adenosine 5'-monophosphate (cAMP)-dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein.
###end article-title 152
###begin article-title 153
Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling.
###end article-title 153
###begin article-title 154
Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.
###end article-title 154
###begin article-title 155
Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation.
###end article-title 155
###begin article-title 156
###xml 136 142 <span type="species:ncbi:10090">murine</span>
Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages.
###end article-title 156
###begin article-title 157
Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.
###end article-title 157
###begin article-title 158
Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans.
###end article-title 158
###begin article-title 159
###xml 16 35 <span type="species:ncbi:5665">Leishmania mexicana</span>
Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production.
###end article-title 159
###begin article-title 160
###xml 72 91 <span type="species:ncbi:5661">Leishmania donovani</span>
RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages.
###end article-title 160
###begin article-title 161
Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
###end article-title 161
###begin article-title 162
###xml 84 89 <span type="species:ncbi:9606">human</span>
Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome.
###end article-title 162
###begin article-title 163
Evolutionary perspective on innate immune recognition.
###end article-title 163
###begin article-title 164
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
###end article-title 164
###begin article-title 165
###xml 64 69 <span type="species:ncbi:9606">human</span>
Regulation of innate immunity signaling and its connection with human diseases.
###end article-title 165
###begin article-title 166
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
###end article-title 166
###begin article-title 167
Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1.
###end article-title 167
###begin article-title 168
###xml 168 183 <span type="species:ncbi:10090">transgenic mice</span>
Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
###end article-title 168
###begin p 169
The authors have declared that no competing interests exist.
###end p 169
###begin p 170
This study is supported by an operating grant from the Canadian Institute of Health Research (CIHR) to M.O. I.A-D. is a recipient of a Fonds de la recherche en sante du Quebec (FRSQ) Ph.D. Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 170

